trial · primary record
avutometinib capsule + defactinib tablet
MPNST (Malignant Peripheral Nerve Sheath Tumor)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2032-01 |
| Primary endpoint | The number of participants that were progression free at four months treated with defactinib and avutometinib. |
| Registry ID | NCT07743554 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:01.780Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07743554
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.